Envelope-Specific Adaptive Immunity following Transplantation of Hematopoietic Stem Cells Modified with VSV-G Lentivirus

[1]  Anthony E. Boitano,et al.  Effective Multi-lineage Engraftment in a Mouse Model of Fanconi Anemia Using Non-genotoxic Antibody-Based Conditioning , 2020, Molecular therapy. Methods & clinical development.

[2]  J. Soulier,et al.  Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia , 2019, Nature Medicine.

[3]  I. Weissman,et al.  Antibody Conditioning Enables MHC-Mismatched Hematopoietic Stem Cell Transplants and Organ Graft Tolerance. , 2019, Cell stem cell.

[4]  Y. Takeuchi,et al.  Use of Heterologous Vesiculovirus G Proteins Circumvents the Humoral Anti-envelope Immunity in Lentivector-Based In Vivo Gene Delivery , 2019, Molecular therapy. Nucleic acids.

[5]  D. Scadden,et al.  Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation , 2019, Nature Communications.

[6]  H. Kiem,et al.  Novel lineage depletion preserves autologous blood stem cells for gene therapy of Fanconi anemia complementation group A , 2018, Haematologica.

[7]  Y. Takeuchi,et al.  Characterization of Antibody Interactions with the G Protein of Vesicular Stomatitis Virus Indiana Strain and Other Vesiculovirus G Proteins , 2018, Journal of Virology.

[8]  W. J. Ramsey,et al.  A Recombinant Vesicular Stomatitis Virus Ebola Vaccine , 2017, The New England journal of medicine.

[9]  J. Wagner,et al.  Hematopoietic cell transplantation in Fanconi anemia: current evidence, challenges and recommendations , 2017, Expert review of hematology.

[10]  Thomas M. Schmitt,et al.  Development of Third-generation Cocal Envelope Producer Cell Lines for Robust Lentiviral Gene Transfer into Hematopoietic Stem Cells and T-cells. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  Otto-Wilhelm Merten,et al.  Production of lentiviral vectors , 2016, Molecular therapy. Methods & clinical development.

[12]  S. Vogel,et al.  CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance , 2015, Proceedings of the National Academy of Sciences.

[13]  B. Sandmaier,et al.  Conditioning regimens for hematopoietic cell transplantation: one size does not fit all. , 2014, Blood.

[14]  S. Russell,et al.  Vesiculovirus Neutralization by Natural IgM and Complement , 2014, Journal of Virology.

[15]  A. Oxenius,et al.  VSV-GP: a Potent Viral Vaccine Vector That Boosts the Immune Response upon Repeated Applications , 2014, Journal of Virology.

[16]  M. Betjes,et al.  Activation‐induced CD137 is a fast assay for identification and multi‐parameter flow cytometric analysis of alloreactive T cells , 2013, Clinical and experimental immunology.

[17]  P. Kurre,et al.  Cell- Cell Transmission of VSV-G Pseudotyped Lentivector Particles , 2013, PloS one.

[18]  D. Schaffer,et al.  Engineering a serum-resistant and thermostable vesicular stomatitis virus G glycoprotein for pseudotyping retroviral and lentiviral vectors , 2013, Gene Therapy.

[19]  A. Figuera,et al.  Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations. , 2011, Blood.

[20]  Songbin Fu,et al.  A Novel Toll-like Receptor That Recognizes Vesicular Stomatitis Virus* , 2010, The Journal of Biological Chemistry.

[21]  Yong Zhao,et al.  2-Gy whole-body irradiation significantly alters the balance of CD4+CD25− T effector cells and CD4+CD25+Foxp3+ T regulatory cells in mice , 2010, Cellular and Molecular Immunology.

[22]  H. Kiem,et al.  Cocal-pseudotyped lentiviral vectors resist inactivation by human serum and efficiently transduce primate hematopoietic repopulating cells. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[23]  K. Karwacz,et al.  HIV-1 Lentiviral Vector Immunogenicity Is Mediated by Toll-Like Receptor 3 (TLR3) and TLR7 , 2010, Journal of Virology.

[24]  A. Annoni,et al.  Immune responses to lentiviral vectors. , 2007, Current gene therapy.

[25]  P. Greenberg,et al.  Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities. , 2007, Blood.

[26]  Zhengfan Jiang,et al.  Vesicular stomatitis virus glycoprotein G activates a specific antiviral Toll-like receptor 4-dependent pathway. , 2007, Virology.

[27]  P. Kurre,et al.  Prolonged Adherence of Human Immunodeficiency Virus-Derived Vector Particles to Hematopoietic Target Cells Leads to Secondary Transduction In Vitro and In Vivo , 2006, Journal of Virology.

[28]  Mario Roederer,et al.  A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles , 2005, Nature Medicine.

[29]  Xian-Yang Zhang,et al.  LSU Digital Commons LSU Digital Commons Altering the tropism of lentiviral vectors through pseudotyping Altering the tropism of lentiviral vectors through pseudotyping , 2022 .

[30]  P. Sinn,et al.  Gene Therapy Progress and Prospects: Development of improved lentiviral and retroviral vectors – design, biosafety, and production , 2005, Gene Therapy.

[31]  A. Auerbach Diagnosis of Fanconi Anemia by Diepoxybutane Analysis , 2003, Current protocols in human genetics.

[32]  P. Sheridan,et al.  VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[33]  I. Chen,et al.  Lentiviral Vectors--the Promise of Gene Therapy Within Reach? , 1999, Science.

[34]  T Friedmann,et al.  Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[35]  G. Pierce,et al.  SUBLETHAL FRACTIONATED TOTAL‐BODY IRRADIATION AND DONOR BONE MARROW INFUSION FOR INDUCTION OF ALLOGRAFT TOLERANCE , 1985, Transplantation.

[36]  W. Wara Immunosuppression associated with radiation therapy. , 1977, International journal of radiation oncology, biology, physics.

[37]  B. Fields,et al.  Human infection with the virus of vesicular stomatitis during an epizootic. , 1967, The New England journal of medicine.

[38]  F. Issa Selective Hematopoietic Stem Cell Ablation Using CD117-Antibody-drug-conjugates Enables Safe and Effective Transplantation With Immunity Preservation , 2019 .

[39]  David A. Williams,et al.  Stem Cell Collection and Gene Transfer in Fanconi Anemia. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.